Opioid Painkillers, with Xanax or Valium is a Killer

Opioid Painkillers, with Xanax or Valium is a Killer

Opioid Painkillers, with Xanax or Valium is a Killer

Mixing opioid painkillers with Rx anxiety and sleep medications is “music” for a “dance with death” aka overdose, a new US study shows.

Of all fatal overdoses from narcotic meds, nearly 30% also involved benzodiazepines, such as Xanax, Klonopin and Valium, the researchers said.

“It’s not news that this combination is not a good one, but despite being well known, it’s gone up over time, and more people are ending up in the hospital because of it,” said lead researcher Dr. Eric Sun. “Patients and doctors really need to think twice about this combination.”

When patients take benzodiazepines along with narcotic painkillers such as Oxycontin, Percocet and Vicodin, the mix lowers the threshold for an overdose, said Sun. He is an assistant professor of anesthesiology, perioperative and pain medicine at Stanford University.

Although this study cannot prove that combining these drugs caused overdoses, the evidence is strong that this can be dangerous.

The guidelines from the US Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) warn doctors of the risks of prescribing narcotic painkillers and benzodiazepines.

The guidelines also advise them to tell their patients of the potential for a narcotic overdose.

In the study collected data on more than 300,000 privately insured patients, aged 18 to 64, who were prescribed a narcotic painkiller between Y’s 2001 and 2013.

In Y 2001, 9% of those patients also had prescriptions for benzodiazepines. By Y 2013, that had increased to 17%, an 80% relative increase, the study findings showed.

Over the years, Rx’s for both narcotic painkillers and benzodiazepines have increased, so it isnot surprising that the number of patients taking both medications is up along with the number of overdoses, the authors said.

“Physicians should think carefully if they find themselves prescribing both drugs for a patient,” they added.

It’s also possible that some patients are getting prescriptions from different doctors who don’t know all the medications the patient is taking, he noted.

Patients should always tell their doctors what drugs they are taking, Sun said. In addition, he suggested that insurance companies can help by monitoring the drugs patients are prescribed.

“These results argue for better surveillance in order to both monitor the risk of these potentially dangerous drug combinations, and to inform patients at risk and their physicians,” he said.

Sun said he couldn’t tell from the data whether these overdoses were intentional or accidental. But he said that he does know that mixing these medications can suppress breathing, and that can send someone to the emergency room.

“It is not necessarily that patients should avoid using both drugs at the same time — after all, there may be reasons to do so — but if they are using both drugs at the same time, they should make sure their doctor is aware of it and OK with it,” Sun explained.

The report was published on 14 Macrdh in the BMJ.

This alarming trend is an important example of low-value care. Low-value care is care that is not based on evidence, potentially unnecessary and dangerous.

Part of the problem is that warnings and guidelines do not always make their way into practice quickly.

“Patients need to be aware of the drugs they are being prescribed, and ask their doctor whether the drug is necessary and is it being prescribed at the lowest dose needed and how long it needs to be used,” Dr. Karaca-Mandic said.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

You must be logged in to post comments :  
CONNECT WITH